András Jeney

942 total citations
46 papers, 781 citations indexed

About

András Jeney is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, András Jeney has authored 46 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 14 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in András Jeney's work include Proteoglycans and glycosaminoglycans research (9 papers), Glycosylation and Glycoproteins Research (8 papers) and Cancer, Hypoxia, and Metabolism (8 papers). András Jeney is often cited by papers focused on Proteoglycans and glycosaminoglycans research (9 papers), Glycosylation and Glycoproteins Research (8 papers) and Cancer, Hypoxia, and Metabolism (8 papers). András Jeney collaborates with scholars based in Hungary, United States and Netherlands. András Jeney's co-authors include József Tı́már, Gábor Pogány, F. Timár, László Kopper, Judit Kralovánszky, Sándor Paku, K. Lapis, Ilona Kovalszky, Anna Sebestyén and Ildikó Krencz and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

András Jeney

46 papers receiving 766 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
András Jeney Hungary 18 438 222 190 189 69 46 781
Jangsoon Lee United States 18 684 1.6× 434 2.0× 187 1.0× 166 0.9× 90 1.3× 40 1.1k
Mike F. Burbridge France 19 567 1.3× 250 1.1× 92 0.5× 178 0.9× 112 1.6× 33 970
Julia Kirshner United States 15 368 0.8× 379 1.7× 58 0.3× 97 0.5× 75 1.1× 30 848
Darcy Bates United States 12 391 0.9× 185 0.8× 105 0.6× 58 0.3× 69 1.0× 17 704
Banibrata Sen United States 15 555 1.3× 358 1.6× 96 0.5× 135 0.7× 133 1.9× 21 923
Kelly Harper Canada 13 294 0.7× 121 0.5× 90 0.5× 155 0.8× 64 0.9× 29 640
Susan Ashwell United States 12 705 1.6× 426 1.9× 130 0.7× 128 0.7× 53 0.8× 18 917
Jelena Grahovac Serbia 10 471 1.1× 287 1.3× 88 0.5× 227 1.2× 110 1.6× 21 853
Isabel Martínez-Lacaci Spain 20 698 1.6× 409 1.8× 141 0.7× 131 0.7× 66 1.0× 30 992
Gretchen M. Unger United States 17 1.2k 2.8× 438 2.0× 154 0.8× 181 1.0× 83 1.2× 29 1.6k

Countries citing papers authored by András Jeney

Since Specialization
Citations

This map shows the geographic impact of András Jeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by András Jeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites András Jeney more than expected).

Fields of papers citing papers by András Jeney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by András Jeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by András Jeney. The network helps show where András Jeney may publish in the future.

Co-authorship network of co-authors of András Jeney

This figure shows the co-authorship network connecting the top 25 collaborators of András Jeney. A scholar is included among the top collaborators of András Jeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with András Jeney. András Jeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petővári, Gábor, Titanilla Dankó, Ildikó Krencz, et al.. (2019). Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells. Pathology & Oncology Research. 26(1). 23–33. 16 indexed citations
2.
Petővári, Gábor, Ildikó Krencz, Titanilla Dankó, et al.. (2018). Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells. Cancer Cell International. 18(1). 211–211. 16 indexed citations
3.
Horváth, Gergő, Gábor Petővári, Ildikó Krencz, et al.. (2018). GABA, glutamine, glutamate oxidation and succinic semialdehyde dehydrogenase expression in human gliomas. Journal of Experimental & Clinical Cancer Research. 37(1). 271–271. 30 indexed citations
4.
Petővári, Gábor, Norbert Szoboszlai, Titanilla Dankó, et al.. (2017). Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells. Journal of Experimental & Clinical Cancer Research. 36(1). 74–74. 18 indexed citations
5.
Szoboszlai, Norbert, Xinghua Guo, Olivér Ozohanics, et al.. (2014). Determination of energy metabolites in cancer cells by porous graphitic carbon liquid chromatography electrospray ionization mass spectrometry for the assessment of energy metabolism. Analytica Chimica Acta. 819. 108–115. 16 indexed citations
6.
Péterfia, Bálint, Tibor Füle, Kornélia Baghy, et al.. (2012). Syndecan-1 Enhances Proliferation, Migration and Metastasis of HT-1080 Cells in Cooperation with Syndecan-2. PLoS ONE. 7(6). e39474–e39474. 34 indexed citations
7.
Dudás, József, et al.. (2007). Extracellular matrix induces doxorubicin-resistance in human osteosarcoma cells by suppression of p53 function. Cancer Biology & Therapy. 6(8). 1251–1257. 20 indexed citations
8.
Jeney, András, et al.. (2006). [Study of drugs against neoplastic metastasis].. PubMed. 50(2). 93–100. 7 indexed citations
9.
Dudás, József, Gábor Pogány, F. Timár, et al.. (2006). Repopulation of osteosarcoma cells after treatment with doxorubicin in the presence of extracellular matrix biopolymers. Cancer Chemotherapy and Pharmacology. 58(3). 334–342. 2 indexed citations
10.
Hauser, Péter, Zoltán Hanzély, Zsuzsanna Jakab, et al.. (2006). Expression and Prognostic Examination of Heat Shock Proteins (HSP 27, HSP 70, and HSP 90) in Medulloblastoma. Journal of Pediatric Hematology/Oncology. 28(7). 461–466. 9 indexed citations
11.
Tevyashova, Anna N., Ferenc Sztaricskai, Gyula Batta, Pál Herczegh, & András Jeney. (2004). Formation of squaric acid amides of anthracycline antibiotics. Synthesis and cytotoxic properties. Bioorganic & Medicinal Chemistry Letters. 14(18). 4783–4789. 25 indexed citations
12.
Tı́már, József, Andrea Ladányi, István Peták, András Jeney, & László Kopper. (2003). Molecular pathology of tumor metastasis III. Pathology & Oncology Research. 9(1). 49–72. 9 indexed citations
13.
Pogány, Gábor, F. Timár, J. Oláh, et al.. (2001). Role of the Basement Membrane in Tumor Cell Dormancy and Cytotoxic Resistance. Oncology. 60(3). 274–281. 17 indexed citations
14.
Tı́már, József, Orsolya Csuka, Zsolt Orosz, András Jeney, & László Kopper. (2001). Molecular pathology of tumor metastasis. Pathology & Oncology Research. 7(3). 217–230. 38 indexed citations
15.
Kralovánszky, Judit, András Jeney, Paul Noordhuis, et al.. (1999). 5-Ethyl-2′-deoxyuridine, a modulator of both antitumour action and pharmacokinetics of 5-fluorouracil. Journal of Cancer Research and Clinical Oncology. 125(12). 675–684. 7 indexed citations
16.
17.
Dudás, József, Gábor Pogány, József Tı́már, et al.. (1998). Inhibition of DNA topoisomerase I activity by heparin sulfate and modulation by basic fibroblast growth factor. Molecular and Cellular Biochemistry. 183(1-2). 11–23. 49 indexed citations
18.
Ladányi, Andrea, et al.. (1998). Cytokine sensitivity of metastatic human melanoma cell lines -simultaneous inhibition of proliferation and enhancement of gelatinase activity. Pathology & Oncology Research. 4(2). 108–114. 7 indexed citations
19.
Kralovánszky, Judit, et al.. (1998). Putative Role of Dihydropyrimidine Dehydrogenase in the Toxic Side Effect of 5-Fluorouracil in Colorectal Cancer Patients. Oncology. 55(5). 468–474. 49 indexed citations
20.
Horváth, Gábor, et al.. (1995). Modification of acute and chronic liver damage by thiazolidine compounds. Pathology & Oncology Research. 1(1). 60–63. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jangsoon Lee Breakdown of academic impact, for papers by Mike F. Burbridge Breakdown of academic impact, for papers by Julia Kirshner Breakdown of academic impact, for papers by Darcy Bates Breakdown of academic impact, for papers by Banibrata Sen Breakdown of academic impact, for papers by Kelly Harper Breakdown of academic impact, for papers by Susan Ashwell Breakdown of academic impact, for papers by Jelena Grahovac Breakdown of academic impact, for papers by Isabel Martínez-Lacaci Breakdown of academic impact, for papers by Gretchen M. Unger
Rankless by CCL
2026